StockWatch
·

ANDHRA CEMENTS LTD. Q2 FY27 Results

ACLQ2 FY27 Results
Filing
Result:Weak· Market: Flat#Margin expansion#Base effect#One-off gain
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue165.9816.8%113.2%
Total Income166.9516.5%112.8%
Expenditure204.617.0%70.0%
PBT-37.6621.2%10.2%
Net Profit-28.3521.1%32.4%
OPM8.57%5.94pp14.35pp
NPM-16.98%8.08pp36.49pp
EPS-3.08179.0%167.7%
View full financials

Cement core metrics (revenue, EBITDA/OPM) are improving nicely off capacity expansion, but ACL remains in an outright loss with adjusted PAT growth only +10.2% (pre-tax loss narrowed just ~10% YoY), with reported +32.4% inflated by a non-cash deferred-tax credit — a loss that isn't a turnaround caps this at weak.

Q2 FY-2027 RESULTS · ACL

Andhra Cements Q2: loss narrows to ₹28.4 Cr YoY as revenue doubles, OPM turns positive

PAT +32.4% YoY · revenue +113.2% · margins expanding

30 Oct 2026 · 3 min read
Revenue

₹165.98 Cr

+113.2% YoY

PAT (standalone)

₹-28.35 Cr

+32.4% YoY

Net margin

-16.98%

+36.5pp YoY

EPS

₹-3.08

Andhra Cements' standalone net loss narrowed to ₹28.35 Cr for the quarter ended September 30, 2026, from ₹41.94 Cr a year earlier and ₹35.93 Cr last quarter, as revenue from operations more than doubled YoY (+113%) to ₹165.98 Cr and grew 17% sequentially — the payoff from the grinding capacity expansion to 3.00 MTPA completed in late September 2026. No consolidated statement accompanies this filing; the company reports standalone only.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹165.98 Cr+16.7%+113.2%
Expenses₹204.61 Cr+7.1%+70%
PAT₹-28.35 Cr+21.1%+32.4%
Net margin-16.98%+8.1pp+36.5pp
EPS₹-3.08-179%-167.7%

The margin story is genuinely stronger: OPM swung to +8.57% from -5.78% YoY and 2.63% QoQ, and NPM improved to -17.0% from -53.5% YoY and -25.1% QoQ. But the 32% YoY narrowing in net loss overstates the underlying operating improvement — at the pre-tax level the loss narrowed only about 10% YoY (₹37.66 Cr vs ₹41.92 Cr), with the gap explained by a ₹9.31 Cr non-cash deferred-tax credit this quarter versus nil tax a year ago (Note 6, Section 115BAA remeasurement based on projected future taxable income). Finance costs (₹31.79 Cr) and depreciation (₹21.06 Cr) together still absorb roughly a third of revenue, as debt funding the expansion pushed total borrowings to ~₹1,184 Cr, up ~6% since March 2026. A separate ₹1.18 Cr MBL Cess provision reversal at the Dachepalli mines (Note 8) added a minor one-off credit to other expenses.

₹
34.3238.2242.1346.0449.9435.8507-2708-1809-0910-0510-2810-30Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹35.85, down 10.3% over the past month of trading.

₹ Cr
-55.26-16.9621.3459.64-29.62Q1 FY26rev ₹100 Cr-41.94Q2 FY26rev ₹78 Cr-44.14Q3 FY26rev ₹110 Cr48.52Q4 FY26rev ₹155 Cr-35.93Q1 FY27rev ₹142 Cr-28.35Q2 FY27rev ₹166 Cr
Quarterly standalone PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

Basic/diluted EPS loss narrowed to ₹3.08 from ₹4.55 YoY and ₹3.90 QoQ on 9.217 Cr shares outstanding.

There is no analyst coverage or consensus estimate for this micro-cap on record — a web search for Q2 FY27 previews turned up none — and the company has issued no formal guidance either in our records or found via search, so the print cannot be graded against street or management expectations. The larger corporate overhang is the proposed Scheme of Amalgamation merging Andhra Cements into parent Sagar Cements Limited (appointed date April 1, 2026, board-approved June 5, 2026), still pending Stock Exchange/SEBI/NCLT approval; once cleared it ends ACL's standalone listing. Statutory auditors B S R and Co issued an unmodified limited-review conclusion on these results.

  • W1

    OPM sustainability now that the 3.00 MTPA grinding capacity is fully online — Q2 FY27 printed +8.57% vs +2.63% in Q1 FY27.

  • W2

    Reliance on non-cash deferred-tax credits (₹9.31 Cr this quarter, per Note 6) to narrow reported PAT versus the smaller ~10% YoY improvement at the PBT level.

  • W3

    Regulatory/NCLT approval progress on the Scheme of Amalgamation with Sagar Cements Limited (appointed date April 1, 2026), which will end ACL's standalone listing once cleared.

Standalone only, no consolidated statement in this filing. EPS row order was ambiguous between two renderings of the same PDF table; resolved via loss/shares(9.217 Cr) cross-check to EPS -3.08 (Q2FY27), -3.90 (Q1FY27), -4.55 (Q2FY26), consistent with context. ₹9.31 Cr of the PAT improvement is a non-cash deferred-tax credit (Note 6, Sec 115BAA remeasurement); a ₹1.18 Cr one-off MBL Cess provision reversal sits in other expenses (Note 8).

Informational and educational content only. Not investment advice.